Near-Term Targets: CordenPharma commits to reduce absolute scope 1 and 2 GHG emissions 55% by 2033 from a 2023 base year.* CordenPharma also commits that 72% of its suppliers by emissions covering purchased goods and services, capital goods, fuel- and energy-related activities, upstream transportation and distribution, and waste generated in operations will have science-based targets by 2029. *The target boundary includes land-related emissions and removals from bioenergy feedstocks.